Cardio Diagnostics Holdings Inc. Warrant (CDIOW) Stock Price
CDIOWStock
$0.01
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta1.50
CDIOW Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-75.71%
Price vs S&P 500 (4W)-61.07%
VGM Score12.57
Industry Peers — In Vitro Diagnostics(18)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|---|---|---|
CDIOWCardio Diagnostics Holdings Inc. Warrant | — | — | F | — | — | — | — | $0.01 |
| IDXXIdexx Laboratories Inc | D | B | B | 9.7x | 12.8% | 62.5% | 14.3% | $560.36 |
| LNTHLantheus Holdings, Inc | C | B | B | 4.2x | 2.4% | 61.0% | 40.7% | $99.70 |
| NEOGNeogen Corp | C | C | A | 2.9x | -0.3% | 47.4% | — | $11.81 |
| CLDXCelldex Therapeutics, Inc | F | F | C | 13683.0x | -97.3% | 17.6% | — | $27.53 |
| NTLAIntellia Therapeutics, Inc | D | D | C | 26.9x | 12.6% | — | — | $11.42 |
| QDELQuidelOrtho Corporation Common Stock | C | C | C | 0.3x | -2.5% | 44.6% | — | $12.91 |
| ACHVAchieve Life Sciences, Inc. | F | F | B | 36.8x | -89.3% | — | — | $6.38 |
| MYGNMyriad Genetics Inc | C | C | D | 0.5x | -3.2% | 68.8% | — | $3.98 |
| TKNOAlpha Teknova, Inc. Common Stock | D | C | B | 8.7x | 12.3% | 34.6% | — | $7.08 |
| NNNNAnbio Biotechnology Class A Ordinary Shares | F | C | F | 34.0x | -5.7% | 89.0% | — | $3.13 |
About Cardio Diagnostics Holdings Inc. Warrant
Cardio Diagnostics Holdings develops AI-powered epigenetic blood tests for detecting and assessing coronary heart disease risk. The company's product suite includes Epi+Gen CHD for symptomatic risk assessment, PrecisionCHD for CHD detection, and Actionable Clinical Intelligence, a platform that delivers personalized patient insights by analyzing epigenetic and genetic biomarkers. These solutions aim to improve cardiovascular disease management and patient outcomes through advanced diagnostic capabilities.